Mutual of America Capital Management LLC Sells 3,764 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Mutual of America Capital Management LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 116,972 shares of the healthcare conglomerate’s stock after selling 3,764 shares during the quarter. UnitedHealth Group comprises 0.6% of Mutual of America Capital Management LLC’s holdings, making the stock its 15th largest position. Mutual of America Capital Management LLC’s holdings in UnitedHealth Group were worth $59,171,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in UNH. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $37,000. DecisionPoint Financial LLC boosted its stake in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares in the last quarter. Legacy Investment Solutions LLC purchased a new stake in UnitedHealth Group during the third quarter worth $57,000. Finally, FPC Investment Advisory Inc. increased its holdings in shares of UnitedHealth Group by 863.6% in the 4th quarter. FPC Investment Advisory Inc. now owns 106 shares of the healthcare conglomerate’s stock valued at $58,000 after acquiring an additional 95 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on UNH shares. Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Up 1.4 %

Shares of UnitedHealth Group stock opened at $474.95 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market cap of $437.09 billion, a PE ratio of 30.64, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The firm has a fifty day moving average price of $516.59 and a 200 day moving average price of $557.16.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the company earned $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be issued a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.77%. UnitedHealth Group’s payout ratio is 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.